Why AI Isn't Ready to Make Medicines

Episode notes

Many in venture capital and biopharma are anointing artificial intelligence the savior of drug discovery - but what can AI actually do? In this eye-opening episode, Michael Marks sits down with Mike Nohaile, CEO of Prellis Biologics, to explore the hype versus reality in AI-enabled drug discovery. Mike details why, despite significant breakthroughs like AlphaFold and recent Nobel Prize win for computational protein design, fully AI-generated medicines still present challenges. He also discusses why we urgently need more effective medicines and details Prellis’ unique system which combines laser printed human organoids and an externalized human immune system with AI, enabling the discovery of fully human antibodies. If you enjoy this episode, please subscribe and leave us a review on your favorite podcast platform.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric MoonshotProgress, Potential, and Possibilities Podcast / Show · on Artificial intelligence92 / 100
• Rebooting Enterprise AI with MCP and KubernetesPractical AI · on Artificial intelligence88 / 100
• The Autonomous Digital Economy Is HereFinding Peak w/ Ryan Hanley · on Venture capital82 / 100
• The Truth About Bootstrapping an AI Startup with David Pourquery (#80)Exit Algorithms · on Venture capital81 / 100
• Brian Murphy: Fundraising $25B Across 44 Funds, $73B Merger, Private Equity, Secondaries, BuffettStartup Ignition Podcast · on Venture capital80 / 100
• #366 Can AI Agents Outperform a Data Scientist? | James Zou, Professor at Stanford UniversityDataFramed · on Protein design80 / 100

• The Moving Bottleneck: Networking, Power, Memory, and the Race to Win AI87 / 100
• Battle for the AI Data Center: Deep Dive on the Semiconductor Supercycle84 / 100
• In-Orbit Manufacturing, AI Data Centers, and the New Space Economy with MIT’s Ariel Ekblaw77 / 100
• The U.S. - China Deep Tech Arms Race79 / 100
• Rare Earth Rush: Strategic Minerals and Tech's New Resource Wars95 / 100